Dr. Redelman-Sidi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-8072- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Infectious Disease, 2008 - 2011
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2004 - 2008
- Tel Aviv University SacklerClass of 2000
Certifications & Licensure
- FL State Medical License 2022 - Present
- NJ State Medical License 2023 - 2025
- NY State Medical License 2007 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 4 citationsBCG-Induced Tumor Immunity Requires Tumor-Intrinsic CIITA Independent of MHC-II.Gil Redelman-Sidi, Anna Binyamin, Anthony C Antonelli, Will Catalano, James Bean, Hikmat Al-Ahmadie, Achim A Jungbluth, Michael S Glickman> ;Cancer Immunology Research. 2022 Oct 4
- 24 citationsBCG in Bladder Cancer Immunotherapy.Song Jiang, Gil Redelman-Sidi> ;Cancers. 2022 Jun 23
- 6 citationsSerial interferon-gamma release assay in lung cancer patients receiving immune checkpoint inhibitors: a prospective cohort study.Kohei Fujita, Paul Elkington, Gil Redelman-Sidi, Osamu Kanai, Yuki Yamamoto, Takuma Imakita, Misato Okamura, Koichi Nakatani, Tadashi Mio> ;Cancer Immunology, Immunotherapy. 2022 Nov 1
- Join now to see all
Hospital Affiliations
- Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: